Abstract
Background
The results of BCT in Japanese women have not been fully evaluated. The Tokyo Women’s Medical University Breast Cancer Society initiated BCT protocols in 1987. Here, we present a retrospective analysis of BCT outcomes and identify prognostic factors.
Methods
The study population comprised 348 patients (353 breasts) with UICC clinical stage 0, I or II breast cancer, for whom wide excision (n = 294), quadrantectomy (n = 56) and tumorectomy (n = 3) were performed. The final pathological margin states were positive in 102 breasts (cancer cells remained within 5 mm of the surgical margin). The whole breast was irradiated to a total dose with 44 Gy/20 fractions or 46 Gy/23 fractions in the patients with negative surgical margins. The patients with positive or close margins received 48.4 Gy/22 fractions or 50 Gy/25 fractions irradiation to the whole breast. All but 2 patients received a radiation boost to the tumor bed and all tumor beds were irradiated to more than 53 Gy. Adjuvant therapy was administered in 240 cases. The median follow-up time was 4.3 years.
Results
The 5-year overall, cause-specific and disease-free survival rates were 95.8%, 97.3% and 92.5%, respectively. Recurrence was observed in 29 patients including 11 patients with loco-regional recurrence. Local recurrence was observed in 6 patients, 5 of whom were premenopausal. The 5-year local control and loco-regional control rates were 98.9% and 96.6%, respectively. T status (T1 to T2) was the only significant prognostic factor for disease-free survival. No severe morbidity has been observed. Cosmetic results were excellent or good in 73% of patients.
Conclusion
Our BCT protocols provide a high rate of local control and good cosmetic outcome. Pathologic margin status was not a major prognostic factor for local recurrence. Long term follow-up is required to reach a definite conclusion on optimal BCT protocols.
Similar content being viewed by others
Abbreviations
- BCT:
-
Breast-conserving therapy
- UICC:
-
Union Internationale Contre 1e Cancer
- ECOG:
-
Eastern Cooperative Oncology Group
- ER:
-
Estrogen receptor
- PgR:
-
Progesterone receptor
- DCC:
-
Dextrancoated charcoal
- EIA:
-
Enzyme immunoassay
- LH-RH:
-
Luteinizing hormone-releasing hormone
- LENT SOMA scale:
-
Late Effects Normal Tissues, Subjective, Objective, Management and Analysis scale
- EORTC:
-
the European Organization for Research and Treatment of Cancer
- We:
-
Wide excision
- Bq:
-
Quadrantectomy
- Tm:
-
Tumorectomy
- inf:
-
Inflammatory type
- Bp:
-
Partial mastectomy
- WB:
-
Whole breast irradiation
- LO:
-
Local boost irradiation
- NSABP:
-
National Surgical Adjuvant Breast and Bowel Project
- Osaka MCCCD:
-
Osaka Medical Center for Cancer and Cardiovascular Diseases
- TWMU:
-
Tokyo Women’s Medical University
References
van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H: Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.J Natl Cancer Inst 92:1143–1150, 2000.
Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N: Twenty-year follow-up of a randomized clinical trial comparing total mastectomy, lumpectomy and lumpectomy with irradiation for the treatment of invasive breast cancer.N Engl J Med 347:1233–1241, 2002.
Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E: Twenty-year follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer.N Engl J Med 347:1227–1232, 2002.
Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, Adami HO: 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial.J Clin Oncol 17:2326–2333, 1999.
Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group.J Natl Cancer Inst 88:1659–1664, 1996.
Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, Smith DC, George WD: Randomized controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group.Lancet 348:708–713, 1996.
Romestaing P, Lehingue Y, Carrie C, Coquard R, Montbarbon X, Ardiet JM, Mamelle N, Gerard JP: Role of a 10-Gy boost in conservation treatment of early breast cancer: results of a randomized clinical trial in Lyon, France.J Clin Oncol 15:963–968, 1997.
Kokubo M, Mitsumori M, Ishikura S, Nagata Y, Fujishiro S, Inamoto T, Mise K, Kodama H, Sasai K, Hiraoka M: Results of breast-conserving therapy for early stage breast cancer: Kyoto University experiences.Am J Clin Oncol 23:499–505, 2000.
Kodaira T, Fuwa N, Itoh Y, Matsumoto A, Kamata M, Furutani K, Sasaoka M, Miura S, Takeuchi T: Aichi Cancer Center 10-year experience with conservative breast treatment of early breast cancer: retrospective analysis regarding failure patterns and factors influencing local control.Int J radiation Oncol Biol Phys 49:1311–1316, 2001.
Horiguchi J, Koibuchi Y, Takei H, Yokoe T, Yamakawa M, Nakajima T, Oyama T, lino Y, Morishita Y: Breast-conserving surgery following radiation therapy of 50 Gy in stages I and II carcinoma of the breast: the experience at one institute in Japan.Oncol Rep 9:1053–1057, 2002.
Komoike Y, Motomura K, Inaji H, Kasugai T, Nose T, Koizumi M, Koyama H: Long-Term Results of Breast Conserving Surgery for Stages I and II Breast Cancer: Experiences at Osaka Medical Center for Cancer and Cardiovascular Diseases.Breast Cancer 9:248–253, 2002.
Koyama H, Inaji H, Noguchi S, Motomura K: Recent progress in breast conserving therapy: from experiences in Japan.Breast Cancer 3:151–160, 1996.
Kajiwara T: Breast-Conserving Therapy: Experience of the Breast Cancer Research Group of Tokyo Women’s Medical College.Breast Cancer 4:1–5, 1997.
Karasawa K: Recent Progress in Breast Conserving Therapy: Form a Point of Radiotherapy.Jap J Cancer Clin 46:657–664, 2000 (in Japanese with English abstract).
The Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer, 14th ed, Kanehara Co, Tokyo, pp20–56, 2000.
Harris JR, Levene MB, Svensson G, Hellman S: Analysis of cosmetic results following primary radiation therapy for stage I and II carcinoma of the breast.Int J radiation Oncol Biol Phys 5:257–261, 1979.
Rubin P, Constine LS 3rd, Fajardo LF, Phillips TL, Wasserman TH: EORTC Late Effects Working Group. Overview of late normal tissues (LENT) scoring system.Radiother Oncol 35:9–10, 1995.
Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, Gonzales-Gonzales D, Horiot JC, Bolla M, Bartelink H: EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale.Radiother Oncol 35:11–15, 1995.
Renton SC, Gazet JC, Ford HT, Corbishley C, Sutcliffe R: The importance of the resection margin in conservative surgery for breast cancer.Eur J Surg Oncol 22:17–22, 1996.
Anscher MS, Jones P, Prosnitz LR, Blackstock W, Hebert M, Reddick R, Tucker A, Dodge R, Leight G Jr, Iglehart JD: Local failure and margin status in early-stage breast carcinoma treated with conservation surgery and radiation therapy.Ann Surg 218:22–28, 1993
Schnitt SJ, Abner A, Gelman R, Connolly JL, Recht A, Duda RB, Eberlein TJ, Mayzel K, Silver B, Harris JR: The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy.Cancer 74:1746–1751, 1994.
Smitt MC, Nowels KW, Zdeblick MJ, Jeffrey S, Carlson RW, Stockdale FE, Goffinet DR: The importance of the lumpectomy surgical margin status in longterm results of breast conservation.Cancer 76:259–267, 1995.
Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ: Outcome at 8 Years After Breast-Conserving Surgery and Radiation Therapy for Invasive Breast Cancer: Influence of Margin Status and Systemic Therapy on Local Recurrence.J Clinic Oncol 18:1668–1675, 2000.
Singletary SE: Surgical margins in patients with earlystage breast cancer treated with breast conservation therapy.Am J Surg 184:383–393, 2002.
Peterson ME, Schultz DJ, Reynolds C, Solin LJ: Outcomes in breast cancer patients relative to margin status after treatment with breast-conserving surgery and radiation therapy: The University of Pennsylvania experience.Int J Radiat Oncol Biol Phys 43:1029–1035, 1999.
Wazer DE, Jabro G, Ruthazer R, Schmid C, Safaii H, Schmidt-Ullrich RK: Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation.Radiat Oncol Investig 7:111–117, 1999.
Vrieling C, Collette L, Fourquet A, Hoogenraad WJ, Horiot JH, Jager JJ, Pierart M, Poortmans PM, Struikmans H, Maat B, Van Limbergen E, Bartelink H: The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC “boost vs no boost” trial. EORTC Radiotherapy and Breast Cancer Cooperative Groups.Radiother Oncol 55:219–232, 2000.
Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L, Pierart M: European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups: Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.N Engl J Med 345:1378–1387, 2001.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Karasawa, K., Obara, T., Shimizu, T. et al. Outcome of breast-conserving therapy in the Tokyo women’s medical university breast cancer society experience. Breast Cancer 10, 341–348 (2003). https://doi.org/10.1007/BF02967655
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02967655